Real-time enrollment status for this hsil, high grade squamous intraepithelial lesion clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:43 PM UTC
| NCT Number | NCT06949800 |
| Recruiting Status | Recruiting |
| Condition | HSIL, High Grade Squamous Intraepithelial Lesion |
| Phase | PHASE2 |
| Target Enrollment | 90 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of California, San Francisco |
| Last Updated on CT.gov | September 15, 2026 (Sep 15, 2026) |
As of October 15, 2026: Clinical trial NCT06949800 is currently recruiting participants. This phase2 study for hsil, high grade squamous intraepithelial lesion is actively seeking new participants at 1 location across the United States. The study is sponsored by University of California, San Francisco. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06949800 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06949800 was last updated Sep 15, 2026 (September 15, 2026). HelloStudys verifies this status automatically.